AC Immune SA SEC filings ACIU
AC Immune SA has 313 filings in SEC EDGAR's recent list, going back to Aug 28, 2015. Its latest annual report, Form 20-F, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 6, 2024 | — |
| F-3/A | Form f-3/a | Jul 26, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 14, 2024 | — |
| 424B5 | Prospectus supplement | Dec 15, 2023 | — |
| 424B5 | Prospectus supplement | May 19, 2022 | — |
| 424B5 | Prospectus supplement | May 5, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 28, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 23, 2020 | — |
| 424B5 | Prospectus supplement | Sep 8, 2020 | — |
| S-8 | Employee stock plan registration | Aug 5, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 24, 2018 | — |
| 424B5 | Prospectus supplement | Jul 20, 2018 | — |
| 424B5 | Prospectus supplement | Jul 19, 2018 | — |
| 424B5 | Prospectus supplement | Jul 17, 2018 | — |
| F-3/A | Form f-3/a | May 25, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | May 4, 2018 | — |
| S-8 | Employee stock plan registration | Mar 8, 2017 | — |
| S-8 | Employee stock plan registration | Sep 29, 2016 | — |
| 424B4 | Prospectus | Sep 23, 2016 | — |
| F-1/A | Amendment no. 7 to form f-1 | Sep 22, 2016 | — |
| FWP | Free writing prospectus | Sep 21, 2016 | — |
| F-1/A | Amendment no. 6 to form f-1 | Sep 21, 2016 | — |
| FWP | Free writing prospectus | Sep 16, 2016 | — |
| F-1/A | Amendment no. 5 to form f-1 | Sep 16, 2016 | — |
| F-1/A | Amendment no. 4 to form f-1 | Sep 13, 2016 | — |
| F-1/A | Amendment no. 3 to form f-1 | Sep 7, 2016 | — |
| F-1/A | Amendment no. 2 to form f-1 | Jul 11, 2016 | — |
| F-1/A | Amendment no. 1 to form f-1 | Jun 15, 2016 | — |
| F-1 | Registration statement (foreign issuer) | May 31, 2016 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACIU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- 1015 Lausanne, Switzerland
- SEC filer status
- Accelerated filer
- SEC CIK
- 1651625
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.